XML 35 R23.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Financial Instruments (Tables) | 6 Months Ended
--- | ---
Mar. 31, 2024
Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract] |
Long-Term Debt | Based on these criteria, the fair market value of long-term debt, including current portion, was as follows (in thousands):
| March 31, 2024 |  | September 30, 2023
| Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Long-Term Debt | $ | 2,386,574 |  |  | $ | 2,291,399 |  |  | $ | 2,384,485 |  |  | $ | 2,210,478 |
Schedule Of Other Investments | The components of the Company's Other Investments are as follows (in thousands):
| At March 31, 2024 |  | At September 30, 2023
Life Insurance Contracts | $ | 43,862 |  |  | $ | 42,242 |
Equity Mutual Fund | 18,291 |  |  | 15,837 |
Fixed Income Mutual Fund | 16,591 |  |  | 15,897 |
| $ | 78,744 |  |  | $ | 73,976 |
Schedule of Derivative Financial Instruments Designated And Qualifying As Cash Flow Hedges On The Statement Of Financial Performance |
The Effect of Derivative Financial Instruments on the Statement of Financial Performance for the
Three Months Ended March 31, 2024 and 2023 (Thousands of Dollars)
Derivatives in Cash Flow Hedging Relationships | Amount of Derivative Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on the Consolidated Statement of Comprehensive Income (Loss) for the Three Months Ended March 31, | Location of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of Income | Amount of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of Income for the Three Months Ended March 31,
| 2024 | 2023 |  | 2024 | 2023
Commodity Contracts | $ | 71,876 |  | $ | 310,623 |  | Operating Revenue | $ | 60,184 |  | $ | (18,768) |
Foreign Currency Contracts | (712) |  | (79) |  | Operating Revenue | (36) |  | (172) |
Total | $ | 71,164 |  | $ | 310,544 |  |  | $ | 60,148 |  | $ | (18,940) |
The Effect of Derivative Financial Instruments on the Statement of Financial Performance for the
Six Months Ended March 31, 2024 and 2023 (Thousands of Dollars)
Derivatives in Cash Flow Hedging Relationships | Amount of Derivative Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on the Consolidated Statement of Comprehensive Income (Loss) for the Six Months Ended March 31, | Location of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of Income | Amount of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of Income for the Six Months Ended March 31,
| 2024 | 2023 |  | 2024 | 2023
Commodity Contracts | $ | 259,865 |  | $ | 607,743 |  | Operating Revenue | $ | 79,939 |  | $ | (177,930) |
Foreign Currency Contracts | 466 |  | 394 |  | Operating Revenue | (82) |  | (351) |
Total | $ | 260,331 |  | $ | 608,137 |  |  | $ | 79,857 |  | $ | (178,281) |

X
- Definition This item represents the fair market value of long-term debt, including current portion + References No definition available. + Details
Name: | nfg_LongTermDebtFairMarketValueTableTextBlock
Namespace Prefix: | nfg_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//320/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 321 -Publisher FASB -URI https://asc.fasb.org//321/tableOfContent Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 325 -Publisher FASB -URI https://asc.fasb.org//325/tableOfContent + Details
Name: | us-gaap_InvestmentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration